In a murine model with 4T1 breast cancer cell implantation, the administration of IL-33 induced the recruitment of NK cells in the lungs, by means of the production of CCL5 by eosinophils and CD8+ T cells, and NK cells activation, through the increase of ST2 expression (receptor for IL-33) [57]. Here, CCL5 is linked to breast cancer.